MedPath
HSA Approval

ROCURONIUM KABI SOLUTION FOR INJECTION/INFUSION 10MG/ML

SIN15106P

ROCURONIUM KABI SOLUTION FOR INJECTION/INFUSION 10MG/ML

ROCURONIUM KABI SOLUTION FOR INJECTION/INFUSION 10MG/ML

October 25, 2016

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Licence HolderFRESENIUS KABI (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

INTRAVENOUS

Medical Information

M03AC09

rocuronium bromide

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

Fresenius Kabi Austria GmbH

Active Ingredients

Rocuronium Bromide

10mg/ml

Rocuronium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ROCURONIUM KABI SOLUTION FOR INJECTION/INFUSION 10MG/ML - HSA Approval | MedPath